Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Alzheimer's disease linked to immunoinflammatory response

Nov. 1, 1996

Eisai files for approval of Aricept

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

Merck NK1 antagonist shows antiemetic activity in ferrets

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Anxiolytic activity of phytomedicine established in patients

Nov. 1, 1996

Melatonergic agents reported by BMS

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...